Reactivation of SARS-CoV-2 infection following recovery from COVID-19

被引:11
|
作者
Chen, Zhihai [1 ]
Xie, Wen [2 ]
Ge, Ziruo [1 ,3 ]
Wang, Yajie [4 ]
Zhao, Hong [2 ]
Wang, Jingjing [2 ]
Xu, Yanli [1 ]
Zhang, Wei [1 ]
Song, Meihua [1 ]
Cui, Shuping [1 ,5 ]
Wang, Xiankun [1 ,3 ]
Pan, Calvin Q. [2 ]
机构
[1] Capital Med Univ, Beijing Ditan Hosp, Ctr Infect Dis, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Ditan Hosp, Ctr Liver Dis, 8 Jingshun East St, Beijing 100015, Peoples R China
[3] Capital Med Univ, Grad Sch, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Ditan Hosp, Dept Clin Lab, Beijing, Peoples R China
[5] Peking Univ, Ditan Teaching Hosp, Beijing, Peoples R China
关键词
Coronavirus reactivation; COVID-19; relapse; Persistent coronavirus infection; Real-Time reverse; transcription-polymerase chain reaction; Recurrent SARS-CoV-2 infection;
D O I
10.1016/j.jiph.2021.02.002
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction: Many individuals test positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA after recovering from the coronavirus disease (COVID-19), but the incidence of reactivation is unknown. We, therefore, estimated the incidence of reactivation among individuals who had recovered from COVID-19 and determined its predictors. Methods: In this retrospective cohort study, patients with COVID-19 were followed up for at least 14 days after two consecutive negative SARS-CoV-2 polymerase chain reaction test results obtained >= 24 h apart, and the frequency of SARS-CoV-2 reactivation was assessed. Results: Of the 109 patients, 29 (27%) experienced reactivation, and seven (24%) of these were symp-tomatic. The mean period for the real-time PCR tests for SARS-CoV-2 from negative to positive results was 17 days. Compared with patients without reactivation, those with reactivation were significantly younger and more likely to have a lymphocyte count of <1500/mu L (odds ratio [OR]: 0.34, 95% confidence interval [CI]: 0.12-0.94) and two or fewer symptoms (OR: 0.20, 95% CI: 0.07-0.55) during the initial episode. Conclusion: Risk-stratified surveillance should be conducted among patients who have recovered from COVID-19. (c) 2021 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:620 / 627
页数:8
相关论文
共 50 条
  • [21] Effect of COVID-19 vaccination on thromboembolic and cardiovascular complications following SARS-CoV-2 infection
    Mercade Besora, Nuria
    Jodicke, Annika M.
    Roel, Elena
    Delmestri, Antonella
    Prats, Clara
    Prieto-Alhambra, Daniel
    Catala Sabate, Marti
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 43 - 43
  • [22] Maternal and infant SARS-CoV-2 antibody responses following maternal COVID-19 infection
    Martin, Melanie A.
    Keith, Monica
    Pace, Ryan M.
    Williams, Janet E.
    Ley, Sylvia H.
    Barbosa-Leiker, Celestina
    Caffe, Beatrice
    Smith, Caroline B.
    Kunkle, Amanda
    Lackey, Kimberly A.
    Navarrete, Alexandra D.
    Pace, Christina D. W.
    Gogel, Alexandra C.
    Eisenberg, Dan T. A.
    Fehrenkamp, Bethaney D.
    Mcguire, Mark A.
    Mcguire, Michelle K.
    Meehan, Courtney L.
    Brindle, Eleanor
    AMERICAN JOURNAL OF BIOLOGICAL ANTHROPOLOGY, 2023, 180 : 112 - 113
  • [23] Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination
    Sekulovski, Metodija
    Mileva, Niya
    Vasilev, Georgi Vasilev
    Miteva, Dimitrina
    Gulinac, Milena
    Peshevska-Sekulovska, Monika
    Chervenkov, Lyubomir
    Batselova, Hristiana
    Vasilev, Georgi Hristov
    Tomov, Latchezar
    Lazova, Snezhina
    Vassilev, Dobrin
    Velikova, Tsvetelina
    BIOMEDICINES, 2023, 11 (10)
  • [24] Multisystem Inflammatory Syndrome in Neonates following Maternal SARS-CoV-2 COVID-19 Infection
    Lakshminrusimha, Satyan
    Hudak, Mark L.
    Dimitriades, Victoria R.
    Higgins, Rosemary D.
    AMERICAN JOURNAL OF PERINATOLOGY, 2022, 39 (11) : 1166 - 1171
  • [25] Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)
    Carrascosa, J. M.
    Morillas, V
    Bielsa, I
    Munera-Campos, M.
    ACTAS DERMO-SIFILIOGRAFICAS, 2020, 111 (09): : 734 - 742
  • [26] COVID-19 (SARS-CoV-2) Infection in Pregnancy: A Systematic Review
    Akhtar, Hubba
    Patel, Chandni
    Abuelgasim, Eyad
    Harky, Amer
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2020, 85 (04) : 295 - 306
  • [27] COVID-19(SARS-CoV-2 infection) in lymphoma patients: A review
    Valentina Bonuomo
    Isacco Ferrarini
    Michele Dell’Eva
    Eugenio Sbisà
    Mauro Krampera
    Carlo Visco
    World Journal of Virology, 2021, (06) : 312 - 325
  • [28] Human genetics of SARS-CoV-2 infection and critical COVID-19
    Mogensen, Trine H.
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (11) : 1417 - 1421
  • [29] Animal and translational models of SARS-CoV-2 infection and COVID-19
    Johansen, M. D.
    Irving, A.
    Montagutelli, X.
    Tate, M. D.
    Rudloff, I
    Nold, M. F.
    Hansbro, N. G.
    Kim, R. Y.
    Donovan, C.
    Liu, G.
    Faiz, A.
    Short, K. R.
    Lyons, J. G.
    McCaughan, G. W.
    Gorrell, M. D.
    Cole, A.
    Moreno, C.
    Couteur, D.
    Hesselson, D.
    Triccas, J.
    Neely, G. G.
    Gamble, J. R.
    Simpson, S. J.
    Saunders, B. M.
    Oliver, B. G.
    Britton, W. J.
    Wark, P. A.
    Nold-Petry, C. A.
    Hansbro, P. M.
    MUCOSAL IMMUNOLOGY, 2020, 13 (06) : 877 - 891
  • [30] SARS-CoV-2 infection (COVID-19): What are we facing?
    Kern, Winfried, V
    Biever, Paul M.
    Rieg, Siegbert
    Panning, Marcus
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2020, 145 (11) : 740 - 746